conference reporter

62nd ASH Annual Meeting and Exposition

Conference Reporter in Aggressive B-Cell Lymphoma to Cover Key Topics Being Presented at the 62nd ASH Annual Meeting and Exposition

by Tom Iarocci, MD

Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. This issue of Conference Reporter  will feature coverage of selected topics in Aggressive B-Cell Lymphoma presented at this year’s ASH annual meeting.

“Effective, well-tolerated, and durable strategies are needed for patients with aggressive B-cell lymphoma who relapse after frontline treatment. As research and development of cellular and immune-based therapies expand, we hope for greatly improved outcomes for these patients in the future.”

Tom Iarocci, MD

The clinicians who were surveyed selected the following expert commentators and topics from the upcoming conference.

Community-Selected Expert Commentators: 

Jeremy S. Abramson, MD, MMSc

Director, Jon and JoAnn Hagler Center for Lymphoma
Jon and JoAnn Hagler Chair in Lymphoma
Massachusetts General Hospital Cancer Center
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Frederick L. Locke, MD

Co-Leader, Moffitt Immuno-Oncology Program
Vice-Chair and Associate Member
Department of Blood and Marrow Transplant and Cellular Immunotherapy
Moffitt Cancer Center
Tampa, FL

David B. Miklos, MD, PhD

Associate Professor of Medicine
Chief, BMT and Cell Therapy
Stanford University Medical Center
Clinical Director, Cancer Cell Therapy Program
Stanford Health Care
Palo Alto, CA

Community-Selected Topics: 

    Cellular and Immune-Based Therapies for Relapsed Aggressive B-Cell Lymphoma
    Treatment of Double-Hit Lymphomas and Other High-Risk Subsets at ASH 2020
    Unmet Treatment Needs in Aggressive B-Cell Lymphoma
    Optimizing Chimeric Antigen Receptor T-Cell Therapy and Response Durability in Aggressive B-Cell Lymphoma
    Aggressive B-Cell Non-Hodgkin Lymphoma: Molecular Profiling and Post-Treatment Surveillance
    ASH 2020: Novel and Evolving Therapeutic Constructs in Aggressive B-Cell Lymphoma


This information is brought to you by Engage Health Media and is not sponsored by, nor a part of, the American Society of Hematology. 

More in Aggressive B-Cell Lymphoma

Thumb

Aggressive B-Cell Lymphoma

Treatment of Double-Hit Lymphomas and Other High-Risk Subsets

conference reporter by Jeremy S. Abramson, MD, MMSc

Several abstracts presented at the 62nd ASH Annual Meeting and Exposition focused on treatments for patients with high-risk variants of aggressive ...READ MORE

Thumb

Aggressive B-Cell Lymphoma

Novel and Evolving Therapeutic Constructs in Aggressive B-Cell Lymphoma

conference reporter by Jeremy S. Abramson, MD, MMSc

Several abstracts presented at the 62nd ASH Annual Meeting and Exposition focused on novel and emerging treatment approaches in aggressive B-cell l...READ MORE

Thumb

Aggressive B-Cell Lymphoma

Unmet Treatment Needs in Aggressive B-Cell Lymphoma

conference reporter by David B. Miklos, MD, PhD

At the 62nd ASH Annual Meeting and Exposition, researchers described varying strategies to address unmet needs in the treatment of aggressive B-cel...READ MORE

More In Conference Reporter

Metastatic Prostate Cancer

Novel and Emerging Treatments for Progressive Metastatic Castration-Resistant Prostate Cancer

conference reporter
by William K. Oh, MD

Metastatic Prostate Cancer

Treatment Sequence in Patients With Castration-Resistant Prostate Cancer

conference reporter
by William K. Oh, MD

Metastatic Prostate Cancer

High-Risk and Locally Advanced Prostate Cancer: Clinical Roundup

conference reporter
by Peter R. Carroll, MD, MPH